Results 21 to 30 of about 9,376,530 (330)

Hematologic Manifestations Of Rheumatic Diseases [PDF]

Journal of Education, Health and Sport, 2018
Hetman Marcin, Kulczyński Marcin, Dobryniewska Wanda, Grzebyk Dominik, Fornal Natalia, Bracik Ewelina, Chromiec Tomasz. Hematologic manifestations of rheumatic diseases. Journal of Education, Health and Sport. 2018;8(9):1197-1206 eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1422464 http://ojs.ukw.edu.pl/index.php/johs/article/view/6041 https:
Hetman, Marcin, Kulczyński, Marcin, Dobryniewska, Wanda, Grzebyk, Dominik, Fornal, Natalia, Bracik, Ewelina, Chromiec, Tomasz   +6 more
openaire   +3 more sources

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

Experimental Hematology & Oncology, 2023
Relapse is a major limitation of chimeric antigen receptor (CAR) T-cell therapy. Here, we speculated that decitabine (DAC) in combination with fludarabine and cyclophosphamide (FC) as a lymphodepletion regimen may improve the efficacy of CD19/CD22 CAR T ...
Yunju Ma, Haiping Dai, Qingya Cui, Sining Liu, Liqing Kang, Xiaying Lian, Wei Cui, Jia Yin, Lingling Liu, Mengjie Cai, Lei Yu, Depei Wu, Xiaowen Tang   +12 more
doaj   +1 more source

Hematologic Disease and Heart Disease

, 2007
Severe anemia is an important problem in patients with underlying coronary heart disease because further reduction in oxygen delivery to myocardium supplied by stenotic coronary arteries may lead to angina or myocardial infarction. Cautious transfusion may be critically important acutely in the patient with an acute coronary syndrome ...
Martin D. Phillips, James T. Willerson
openalex   +3 more sources

Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.

Hematology. American Society of Hematology. Education Program, 2020
Corticosteroids constitute a first-line therapy for adults and children suffering from nonmalignant immune-mediated hematologic diseases. However, high disease relapse rates during the tapering period or upon drug discontinuation result in long-term ...
Luis Malpica, S. Moll
semanticscholar   +1 more source

Hematologic manifestations of celiac disease

Blood, 2006
AbstractCeliac disease is a common systemic disorder that can have multiple hematologic manifestations. Patients with celiac disease may present to hematologists for evaluation of various hematologic problems prior to receiving a diagnosis of celiac disease.
Þorvarður R. Hálfdánarson, Mark R. Litzow, Joseph A. Murray   +2 more
openalex   +5 more sources

Viral Disease in Hematology

Hematology, 2000
As part of the international outreach of the American Society of Hematology, this review addresses some aspects of the genetics, biology, epidemiology, and clinical relevance of viruses that cause a variety of hematopoietic disorders in human populations.
Genoveffa Franchini, Richard F. Ambinder, Michèle Barry   +2 more
openaire   +3 more sources

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia

Experimental Hematology & Oncology, 2022
Acute myeloid leukemia (AML) is a complex, heterogeneous malignant hematologic disease. Although multiple prognostic-related genes gave been explored in previous studies, there are still many genes whose prognostic value remains unclear. In this study, a
Xueqian Li, Jiaqian Qi, Xiaofei Song, Xiaoyan Xu, Tingting Pan, Hong Wang, Jingyi Yang, Yue Han   +7 more
doaj   +1 more source

Roles of the intestinal microbiota and microbial metabolites in acute GVHD

Experimental Hematology & Oncology, 2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most curative strategies for the treatment of many hematologic malignancies and diseases. However, acute graft-versus-host disease (GVHD) limits the success of allo-HSCT.
Dandan Lin, Bo Hu, Pengfei Li, Ye Zhao, Yang Xu, Depei Wu   +5 more
doaj   +1 more source

CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

Biomarker Research, 2023
It was previously believed that patients with Ph-like ALL had poorer prognosis compared with other B-ALL subgroups due to resistance to conventional chemotherapy and lack of targeted drugs.
Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang   +10 more
doaj   +1 more source

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Journal of Hematology & Oncology, 2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are limited.
Qingya Cui, Chongsheng Qian, Nan Xu, Liqing Kang, Haiping Dai, Wei Cui, Baoquan Song, Jia Yin, Zheng Li, Xiaming Zhu, Changju Qu, Tianhui Liu, Wenhong Shen, Mingqing Zhu, Lei Yu, Depei Wu, Xiaowen Tang   +16 more
doaj   +1 more source